AMPHETAMINE SULFATE (amphetamine) by Teva is clinical pharmacology amphetamines are non-catecholamine, sympathomimetic amines with cns stimulant activity. Approved for attention deficit hyperactivity disorder (adhd) in patients 6 years, older () limitations of use the use of dyanavel xr is not recommended in pediatric patients younger than 6 years of age because they had higher plasma exposure, a higher incidence of adverse reactions (e. First approved in 2018.
Drug data last refreshed 19h ago
CLINICAL PHARMACOLOGY Amphetamines are non-catecholamine, sympathomimetic amines with CNS stimulant activity. Peripheral actions include elevations of systolic and diastolic blood pressures, and weak bronchodilator, and respiratory stimulant action. Amphetamine, as the racemic form, differs from…
Worked on AMPHETAMINE SULFATE at Teva? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
A Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants Receiving a Single Dose of Methamphetamine
Maternal Outcomes With Methamphetamine Use and Cardiac Assessment for Rural Dissemination (MOM CARD)
Methamphetamine Use Disorder Support in Heart Failure Pilot Study
Testing an Accelerated TMS Protocol for Methamphetamine Use Disorder
Rural Community Peer Partnerships for Improving Methamphetamine-Associated Heart Failure Screening and Engagement